nach oben

Erschienen in:

01.03.2013 | Original paper

Racial disparities in advanced-stage colorectal cancer survival

verfasst von: Kristin Wallace, Elizabeth G. Hill, David N. Lewin, Grace Williamson, Stephanie Oppenheimer, Marvella E. Ford, Michael J. Wargovich, Franklin G. Berger, Susan W. Bolick, Melanie B. Thomas, Anthony J. Alberg

Erschienen in: Cancer Causes & Control | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

African-Americans (AA) have a higher incidence of and lower survival from colorectal cancer (CRC) compared with European Americans (EA). In the present study, statewide, population-based data from South Carolina Central Cancer Registry are used to investigate the relationship between race and age on advanced-stage CRC survival.

Methods

The study population was comprised of 3,865 advanced pathologically documented colon and rectal adenocarcinoma cases diagnosed between 01 January 1996 and 31 December 2006: 2,673 (69 %) EA and 1,192 (31 %) AA. Kaplan–Meier methods were used to generate median survival time and corresponding 95 % confidence intervals (CI) by race, age, and gender. Factors associated with survival were evaluated by fitting Cox proportional hazards regression models to generate hazard ratios (HR) and 95 % CI.

Results

We observed a significant interaction between race and age on CRC survival (p = 0.04). Among younger patients (<50 years), AA race was associated with a 1.34 times (95 % CI 1.06–1.71) higher risk of death compared with EA. Among older patients, we observed a modest increase in risk of death among AA men compared with EA [HR 1.16 (95 % CI 1.01–1.32)] but no difference by race between women [HR 0.94 (95 % CI 0.82–1.08)]. Moreover, we observed that the disparity in survival has worsened over the past 15 years.

Conclusions

Future studies that integrate clinical, molecular, and treatment-related data are needed for advancing understanding of the racial disparity in CRC survival, especially for those <50 years old.

Siegel R, Naishadham D, Jemal A (2012) Cancer statistics. CA Cancer J Clin 62:10–29PubMedCrossRef

Freeman HP, Alshafie TA (2002) Colorectal carcinoma in poor blacks. Cancer 94:2327–2332PubMedCrossRef

Polite BN, Dignam JJ, Olopade OI (2005) Colorectal cancer and race: understanding the differences in outcomes between African Americans and whites. Med Clin North Am 89:771–793PubMedCrossRef

Albano JD, Ward E, Jemal A, Anderson R, Cokkinides VE, Murray T et al (2007) Cancer mortality in the United States by education level and race. J Natl Cancer Inst 99:1384–1394PubMedCrossRef

Robbins AS, Siegel RL, Jemal A (2012) Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008. J Clin Oncol 30:401–405

Soneji S, Iyer SS, Armstrong K, Asch DA (2010) Racial disparities in stage-specific colorectal cancer mortality: 1960-2005. Am J Public Health 100:1912-1916

Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW et al (2009) Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 27:3677–3683PubMedCrossRef

Sanoff HK, Sargent DJ, Green EM, McLeod HL, Goldberg RM (2009) Racial differences in advanced colorectal cancer outcomes and pharmacogenetics: a subgroup analysis of a large randomized clinical trial. J Clin Oncol 27:4109–4115PubMedCrossRef

White A, Vernon SW, Franzini L, Du XL Racial disparities in colorectal cancer survival: to what extent are racial disparities explained by differences in treatment, tumor characteristics, or hospital characteristics? Cancer 116:4622–4631

10.

Demissie K, Oluwole OO, Balasubramanian BA, Osinubi OO, August D, Rhoads GG (2004) Racial differences in the treatment of colorectal cancer: a comparison of surgical and radiation therapy between Whites and Blacks. Ann Epidemiol 14:215–221PubMedCrossRef

11.

Baldwin LM, Dobie SA, Billingsley K, Cai Y, Wright GE, Dominitz JA et al (2005) Explaining black-white differences in receipt of recommended colon cancer treatment. J Natl Cancer Inst 97:1211–1220PubMedCrossRef

12.

Cooper GS, Yuan Z, Landefeld CS, Rimm AA (1996) Surgery for colorectal cancer: race-related differences in rates and survival among medicare beneficiaries. Am J Public Health 86:582–586PubMedCrossRef

13.

Cook AD, Single R, McCahill LE (2005) Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000. Ann Surg Oncol 12:637–645PubMedCrossRef

14.

Le H, Ziogas A, Lipkin SM, Zell JA (2008) Effects of socioeconomic status and treatment disparities in colorectal cancer survival. Cancer Epidemiol Biomarkers Prev 17:1950–1962PubMedCrossRef

15.

Polite BN, Sing A, Sargent DJ, Grothey A, Berlin J, Kozloff M, et al (2012) Exploring racial differences in outcome and treatment for metastatic colorectal cancer: results from a large prospective observational cohort study (BRiTE). Cancer 118:1083–1090

16.

Meguid RA, Slidell MB, Wolfgang CL, Chang DC, Ahuja N (2008) Is there a difference in survival between right- versus left-sided colon cancers? Ann Surg Oncol 15:2388–2394PubMedCrossRef

17.

Gatta G, Capocaccia R, De Angelis R, Stiller C, Coebergh JW, Group EW (2003) Cancer survival in European adolescents and young adults. Eur J Cancer 39:2600–2610PubMedCrossRef

18.

O’Connell JB, Maggard MA, Ko CY (2004) Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 96:1420–1425PubMedCrossRef

19.

Wray CM, Ziogas A, Hinojosa MW, Le H, Stamos MJ, Zell JA (2009) Tumor subsite location within the colon is prognostic for survival after colon cancer diagnosis. Dis Colon Rectum 52:1359–1366PubMedCrossRef

20.

O’Connell JB, Maggard MA, Liu JH, Etzioni DA, Livingston EH, Ko CY (2004) Do young colon cancer patients have worse outcomes? World J Surg 28:558–562PubMedCrossRef

21.

Yantiss RK, Goodarzi M, Zhou XK, Rennert H, Pirog EC, Banner BF et al (2009) Clinical, pathologic, and molecular features of early-onset colorectal carcinoma. Am J Surg Pathol 33:572–582PubMedCrossRef

22.

Wallace K, Seabrook M, Stinson M, Gilchrist G, Wortham D, Davis A, et al (2010) Results from a colonoscopy based screening program for the uninsured: a pilot study from South Carolina. ACG, San Antonio, TX, pp P829

23.

Derwinger K, Kodeda K, Gerjy R (2010) Age aspects of demography, pathology and survival assessment in colorectal cancer. Anticancer Res 30:5227–5231

24.

Wang L, Hollenbeak CS, Stewart DB (2010) Node yield and node involvement in young colon cancer patients: is there a difference in cancer survival based on age? J Gastrointest Surg 14:1355–1361

25.

Perea J, Alvaro E, Rodriguez Y, Gravalos C, Sanchez-Tome E, Rivera B et al (2010) Approach to early-onset colorectal cancer: clinicopathological, familial, molecular and immunohistochemical characteristics. World J Gastroenterol 16:3697–3703

26.

Dozois EJ, Boardman LA, Suwanthanma W, Limburg PJ, Cima RR, Bakken JL et al (2008) Young-onset colorectal cancer in patients with no known genetic predisposition: can we increase early recognition and improve outcome? Medicine (Baltimore) 87:259–263CrossRef

27.

Hemminki K, Santi I, Weires M, Thomsen H, Sundquist J, Bermejo JL (2010) Tumor location and patient characteristics of colon and rectal adenocarcinomas in relation to survival and TNM classes. BMC Cancer 10:688

28.

Hendifar A, Yang D, Lenz F, Lurje G, Pohl A, Lenz C et al (2009) Gender disparities in metastatic colorectal cancer survival. Clin Cancer Res 15:6391–6397PubMedCrossRef

29.

Koo JH, Leong RW Sex differences in epidemiological, clinical and pathological characteristics of colorectal cancer. J Gastroenterol Hepatol 25:33–42

30.

Qaseem A, Denberg TD, Hopkins RH Jr, Humphrey LL, Levine J, Sweet DE, et al (2012) Screening for colorectal cancer: a guidance statement from the American College of Physicians. Ann Intern Med 156:378–386

31.

Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM et al (2009) American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol 104:739–750PubMedCrossRef

32.

Ashktorab H, Smoot DT, Farzanmehr H, Fidelia-Lambert M, Momen B, Hylind L et al (2005) Clinicopathological features and microsatellite instability (MSI) in colorectal cancers from African Americans. Int J Cancer 116:914–919PubMedCrossRef

33.

Kumar K, Brim H, Giardiello F, Smoot DT, Nouraie M, Lee EL et al (2009) Distinct BRAF (V600E) and KRAS mutations in high microsatellite instability sporadic colorectal cancer in African Americans. Clin Cancer Res 15:1155–1161PubMedCrossRef

34.

Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H et al (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA 291:1701–1712PubMedCrossRef

35.

Newcomb PA, Longnecker MP, Storer BE, Mittendorf R, Baron J, Clapp RW et al (1995) Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women. Am J Epidemiol 142:788–795PubMed

36.

Mandelson MT, Miglioretti D, Newcomb PA, Harrison R, Potter JD (2003) Hormone replacement therapy in relation to survival in women diagnosed with colon cancer. Cancer Causes Control 14:979–984PubMedCrossRef

37.

Amend K, Hicks D, Ambrosone CB (2006) Breast cancer in African-American women: differences in tumor biology from European-American women. Cancer Res 66:8327–8330PubMedCrossRef

38.

Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492–2502PubMedCrossRef

39.

Shavers VL (2007) Racial/ethnic variation in the anatomic subsite location of in situ and invasive cancers of the colon. J Natl Med Assoc 99:733–748PubMed

40.

Thornton JG, Morris AM, Thornton JD, Flowers CR, McCashland TM (2007) Racial variation in colorectal polyp and tumor location. J Natl Med Assoc 99:723–728PubMed

41.

Ashktorab H, Nouraie M, Hosseinkhah F, Lee E, Rotimi C, Smoot D (2009) A 50-year review of colorectal cancer in African Americans: implications for prevention and treatment. Dig Dis Sci 54:1985–1990PubMedCrossRef

42.

Kalady MF, de Campos-Lobato LF, Stocchi L, Geisler DP, Dietz D, Lavery IC, et al (2009) Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer. Ann Surg 582–589

43.

Shen L, Toyota M, Kondo Y, Lin E, Zhang L, Guo Y et al (2007) Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci USA 104:18654–18659PubMedCrossRef

44.

Suehiro Y, Wong CW, Chirieac LR, Kondo Y, Shen L, Webb CR et al (2008) Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma. Clin Cancer Res 14:2560–2569PubMedCrossRef

45.

Jass JR (2007) Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50:113–130PubMedCrossRef

46.

Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Meyerhardt JA, Loda M, et al (2008) CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut 90–96

47.

Kaneda A, Yagi K (2011) Two groups of DNA methylation markers to classify colorectal cancer into three epigenotypes. Cancer Sci 102:18–24

48.

Issa JP (2004) CpG island methylator phenotype in cancer. Nat Rev Cancer 4:988–993PubMedCrossRef

49.

Issa JP (2008) Colon cancer: it’s CIN or CIMP. Clin Cancer Res 14:5939–5940PubMedCrossRef

50.

Sylvester BE, Huo D, Khramtsov A, Zhang J, Smalling RV, Olugbile S, et al (2012) Molecular analysis of colorectal tumors within a diverse patient cohort at a single institution. Clin Cancer Res 18:350–359

51.

Mitchell EP (1054) Prognostic impact of race and ethnicity in the treatment of colorectal cancer. Med Clin North Am 2005(89):1045–1057

52.

Schrag D, Gelfand SE, Bach PB, Guillem J, Minsky BD, Begg CB (2001) Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results–Medicare. J Clin Oncol 19:3712–3718PubMed

53.

Dominitz JA, Samsa GP, Landsman P, Provenzale D (1998) Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system. Cancer 82:2312–2320PubMedCrossRef

Titel: Racial disparities in advanced-stage colorectal cancer survival
verfasst von: Kristin Wallace
Elizabeth G. Hill
David N. Lewin
Grace Williamson
Stephanie Oppenheimer
Marvella E. Ford
Michael J. Wargovich
Franklin G. Berger
Susan W. Bolick
Melanie B. Thomas
Anthony J. Alberg
Publikationsdatum: 01.03.2013
Verlag: Springer Netherlands
Erschienen in: Cancer Causes & Control / Ausgabe 3/2013
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-012-0133-5

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Springer Medizin

Racial disparities in advanced-stage colorectal cancer survival